BOLT
Closed
Bolt Biotherapeutics
6.
0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 5.77
Day's Range: 5.71 - 6.21
Send
sign up or login to leave a comment!
When Written:
1.39
Bolt Biotherapeutics is a biotechnology company that specializes in developing immune-stimulating therapies for cancer treatment. The company was founded in 2015 and is headquartered in Redwood City, California.
Bolt Biotherapeutics' technology platform is based on a unique approach called Immune-Stimulating Antibody Conjugates (ISACs). ISACs are designed to selectively deliver immune-stimulating agents to tumor cells, triggering an immune response that can help eliminate cancer cells.
The company's lead product candidate, BDC-1001, is an ISAC that targets HER2-positive breast cancer. Bolt Biotherapeutics has also developed a pipeline of other ISACs targeting different types of cancer.
Bolt Biotherapeutics has raised over $200 million in funding from investors, including Pfizer Ventures, Novo Holdings, and Pivotal bioVenture Partners. The company has also collaborated with other biotech and pharmaceutical companies, including BioNTech and Genentech.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Bolt Biotherapeutics' technology platform is based on a unique approach called Immune-Stimulating Antibody Conjugates (ISACs). ISACs are designed to selectively deliver immune-stimulating agents to tumor cells, triggering an immune response that can help eliminate cancer cells.
The company's lead product candidate, BDC-1001, is an ISAC that targets HER2-positive breast cancer. Bolt Biotherapeutics has also developed a pipeline of other ISACs targeting different types of cancer.
Bolt Biotherapeutics has raised over $200 million in funding from investors, including Pfizer Ventures, Novo Holdings, and Pivotal bioVenture Partners. The company has also collaborated with other biotech and pharmaceutical companies, including BioNTech and Genentech.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








